Weight No Longer: Addressing Overweight/Obesity as an Integral Part of Type 2 Diabetes Management.
Post-Test/Evaluation
Exit Survey
Questions marked with a
*
are required
20%
Contact Information
First Name
Last Name
Email Address
Credentials/Degree (MD, DO, RN, etc.)
Date of Participation
Month
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
Day
01
02
03
04
05
06
07
08
09
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Year
2018
2019
2020
2021
2022
2023
2024
2025
What percentage of participants in the weight-management arm of the Diabetes Remission Clinical Trial (DiRECT) open-label trial achieved diabetes remission?
18%
46%
66%
82%
Which of the following glucose-lowering therapies has demonstrated the highest efficacy for weight loss in patients with type 2 diabetes?
Tirzepatide
Dulaglutide
Sitagliptin
Metformin
Sylvia is a 66-year-old woman with T2DM new to your practice. She presents for her 6-month diabetes assessment. She appears to have obesity, but you do not know her BMI, as she refused to be weighed. Her blood pressure is 130/80 mm and her A1C is 8.3%. How should you bring up the topic of her weight?
Ask if it is now a good time for discuss how her weight and health may be affecting each other and how you can work on it together
Do not mention it if she has not brought it forward as a concern
Tell her that her weight is a probable cause of her diabetes and high blood pressure
Refer her to a lifestyle modification program that includes weight management and exercise
Start
Powered by
QuestionPro
Loading...
close
drag_indicator
close
Yes
Cancel
Continue
Answer Question
Continue Without Answering
Keep Data
Discard
close